These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 36912232

  • 1. O-Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases.
    Labourel A, Parrou JL, Deraison C, Mercier-Bonin M, Lajus S, Potocki-Veronese G.
    Essays Biochem; 2023 Apr 18; 67(3):331-344. PubMed ID: 36912232
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron.
    Schaus SR, Vasconcelos Pereira G, Luis AS, Madlambayan E, Terrapon N, Ostrowski MP, Jin C, Henrissat B, Hansson GC, Martens EC.
    mBio; 2024 Aug 14; 15(8):e0003924. PubMed ID: 38975756
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron.
    Schaus SR, Vasconcelos Periera G, Luis AS, Madlambayan E, Terrapon N, Ostrowski MP, Jin C, Hansson GC, Martens EC.
    bioRxiv; 2024 Jan 16. PubMed ID: 38293123
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mucins in inflammatory bowel diseases and colorectal cancer.
    Sheng YH, Hasnain SZ, Florin TH, McGuckin MA.
    J Gastroenterol Hepatol; 2012 Jan 16; 27(1):28-38. PubMed ID: 21913981
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.
    Fang J, Wang H, Zhou Y, Zhang H, Zhou H, Zhang X.
    Exp Mol Med; 2021 May 16; 53(5):772-787. PubMed ID: 34002011
    [Abstract] [Full Text] [Related]

  • 18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G.
    Dan Med J; 2015 Jan 16; 62(1):B4973. PubMed ID: 25557335
    [Abstract] [Full Text] [Related]

  • 19. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
    Kudelka MR, Stowell SR, Cummings RD, Neish AS.
    Nat Rev Gastroenterol Hepatol; 2020 Oct 16; 17(10):597-617. PubMed ID: 32710014
    [Abstract] [Full Text] [Related]

  • 20. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis.
    Yamada T, Hino S, Iijima H, Genda T, Aoki R, Nagata R, Han KH, Hirota M, Kinashi Y, Oguchi H, Suda W, Furusawa Y, Fujimura Y, Kunisawa J, Hattori M, Fukushima M, Morita T, Hase K.
    EBioMedicine; 2019 Oct 16; 48():513-525. PubMed ID: 31521614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.